Reply - 27/11/13
Doi : 10.1016/j.jaci.2013.09.013
Simon G.A. Brown, MBBS, PhD, FACEM a, b 
, Shelley F. Stone, PhD a, Daniel M. Fatovich, MBBS, PhD, FACEM a, b, Geoffrey K. Isbister, MBBS, MD, FACEM c
, Shelley F. Stone, PhD a, Daniel M. Fatovich, MBBS, PhD, FACEM a, b, Geoffrey K. Isbister, MBBS, MD, FACEM c a Centre for Clinical Research in Emergency Medicine, Western Australian Institute for Medical Research and the University of Western Australia, Perth, Australia
b Department of Emergency Medicine, University of Western Australia, Royal Perth Hospital, Perth, Australia
c Department of Clinical Toxicology and Pharmacology, Calvary Mater Hospital and the Discipline of Clinical Pharmacology, University of Newcastle, Newcastle, New South Wales, Australia
Le texte complet de cet article est disponible en PDF.
| Disclosure of potential conflict of interest: S. Brown has received grants from the National Health and Medical Research Council, the Royal Perth Hospital Medical Research Foundation, the Fremantle Hospital Medical Research Foundation, and the Food Allergy and Anaphylaxis Network. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2013
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 132 - N° 6
P. 1457 - décembre 2013 Retour au numéro
Article précédent
- Anaphylaxis: Clinical features and mediator release patterns
- Peter Vadas, Gary Liss
- Human basophils lack the capacity to drive memory CD4+ T cells toward the IL-22 response
- Meenu Sharma, Srini V. Kaveri, Jagadeesh Bayry
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?